Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of ZYIL1 Oral Capsules for the Treatment of Patients With Mild to Moderately Active Ulcerative Colitis Resistant or Intolerant to Oral Aminosalicylates [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the efficacy and safety of ZYIL1 oral capsules in patients with mild to moderately active ulcerative colitis resistant or intolerant to…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• ZYIL1

Snippet

Sponsor: Zydus Lifesciences Limited | Conditions: Ulcerative Colitis | Phase 2 | Status: COMPLETED